ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,792.19
-0.60%
US Tech 100
20,080.40
-1.02%
Dow Jones
42,069.97
0.31%
Brent Oil
80.685
0.09%
Bitcoin
91,627.90
-3.02%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Australia
  5. ASX

  6. Visioneering Technologies Inc (VTI) Quote

Visioneering Technologies Inc

Visioneering Technologies Inc (VTI)

Vanguard Total Stock Market ETF
Valdor Technology International Inc
Valdor Technology International Inc
0.057
0.001
(1.79%)
Closed January 13 12:00AM
Delayed by 20 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
0.057
Bid
0.043
Ask
0.066
Volume
35,692
0.057 Day's Range 0.064
0.039 52 Week Range 0.27
Market Cap
3.121M
Previous Close
0.056
Open
0.061
Last Trade
10000
@
0.057
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
97,006
Shares Outstanding
54,755,883
Dividend Yield
-
PE Ratio
-0.95
Earnings Per Share (EPS)
-0.06
Revenue
8.67M
Net Profit
-3.45M

About Visioneering Technologies Inc

Sector
Med, Dental, Hosp Eq-whsl
Industry
Med, Dental, Hosp Eq-whsl
Website
www.vtivision.com
Headquarters
Atlanta, Georgia, USA
Founded
-
Visioneering Technologies Inc is listed in the Med, Dental, Hosp Eq-whsl sector of the Australian Stock Exchange with ticker VTI. The last closing price for Visioneering Technologies was AUD0.06. Over the last year, Visioneering Technologies shares have traded in a share price range of AUD 0.039 to AUD 0.27.

Visioneering Technologies currently has 54,755,883 shares outstanding. The market capitalization of Visioneering Technologies is AUD3.07 million. Visioneering Technologies has a price to earnings ratio (PE ratio) of -0.95.

Ask ADVFN Intelligence (AI)

VTI Latest News

More News

Benefits in a Pandemic: NaturalVue® Offers Multiple Solutions for Patients and Eye Care Practitioners

   Highlights: COVID-19 home confinement of children is associated with up to 3X increase in prevalence of myopia in children 6 to 8 years old 18 months into the global COVID-19 Pandemic, VTI...

June 01 2021
Business Wire

Mature Presbyopes Clinical Research Update Presented at Global Specialty Lens Symposium (GSLS)

Data shows that patients with > +1.75 ADD power and above age 55 achieved vision comparable to spectacle acuity at every distance with NaturalVue Multifocal1 US-based medical device company...

February 06 2020
Business Wire

The Science Behind NaturalVue’s Neurofocus Optics® Technology Presented at American Academy of Optometry

Poster illustrates the Uninterrupted Plus Power Curve in the Central Optic Zone US-based medical device company and manufacturer of the NaturalVue® (etafilcon A) Multifocal 1 Day Contact Lenses...

October 25 2019
Business Wire

Craig Johnson Has Joined Visioneering Technologies Inc. as Quality Specialist

Craig Johnson joined Visioneering Technologies, Inc. in the role of Quality Specialist, based in their Alpharetta, GA Headquarters. Johnson will be responsible for ongoing management of field...

October 15 2019
Business Wire

ADDING and REPLACING Visioneering Expands into Asia with Receipt of Certificate of Listing in Hong Kong

Please replace the release dated July 31, 2019, with the following version due to additional information. US-based medical device company and producer of the NaturalVue® (etafilcon A) Multifocal...

August 09 2019
Business Wire

Suzette Tineo to Lead Territory Management Efforts for NaturalVue® Contact Lenses in Los Angeles

To ensure its valued customers receive the best service possible Visioneering Technologies Inc. (VTI), announced today that experienced sales executive Suzette Tineo has joined VTI as a Territory...

August 05 2019
Business Wire

Visioneering Expands Into Asia With Securing of Regulatory Registration in Hong Kong

US-based medical device company and producer of the NaturalVue® (etafilcon A) Multifocal 1 Day Contact Lenses Visioneering Technologies, Inc (ASX: VTI) (‘Visioneering’ or ‘the Company’) is...

July 31 2019
Business Wire

 Visioneering Wins Award of Excellence for Its NaturalVue® Multifocal 1 Day Contact Lenses at Australia’s Largest Eyecare...

US-based medical device company Visioneering Technologies Inc. (ASX: VTI) (‘Visioneering’ or ‘The Company’) is pleased to announce that it has received the Award of Excellence for its innovative...

July 22 2019
Business Wire

Visioneering Technologies Promotes Cynthia Flynn to Senior Territory Manager for the Austin/San Antonio Area

As the company continues its expansion, Visioneering Technologies Inc. (VTI), has announced the promotion of Cynthia Flynn to Senior Territory Manager in the Austin and San Antonio markets. This...

July 16 2019
Business Wire

Visioneering Technologies Announces Mat Hamilton as the Executive Territory Manager for Boston

As the company continues its expansion, Visioneering Technologies Inc. (VTI), has announced that experienced sales executive Mat Hamilton has joined VTI as the Executive Territory Manager to...

May 22 2019
Business Wire
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.003-50.060.0640.056124920.05677203DE
40.00611.76470588240.0510.0640.0391417040.04558567DE
12-0.068-54.40.1250.1450.039970060.05516466DE
26-0.083-59.28571428570.140.150.039591270.06400697DE
52-0.193-77.20.250.270.039475410.09645855DE
156-0.883-93.93617021280.940.970.039313710.22675867DE
2600.0121.27659574470.0471.390.01110231620.0273154DE

VTI - Frequently Asked Questions (FAQ)

What is the current Visioneering Technologies share price?
The current share price of Visioneering Technologies is AUD 0.057
How many Visioneering Technologies shares are in issue?
Visioneering Technologies has 54,755,883 shares in issue
What is the market cap of Visioneering Technologies?
The market capitalisation of Visioneering Technologies is AUD 3.07M
What is the 1 year trading range for Visioneering Technologies share price?
Visioneering Technologies has traded in the range of AUD 0.039 to AUD 0.27 during the past year
What is the PE ratio of Visioneering Technologies?
The price to earnings ratio of Visioneering Technologies is -0.95
What is the cash to sales ratio of Visioneering Technologies?
The cash to sales ratio of Visioneering Technologies is 0.38
What is the reporting currency for Visioneering Technologies?
Visioneering Technologies reports financial results in USD
What is the latest annual turnover for Visioneering Technologies?
The latest annual turnover of Visioneering Technologies is USD 8.67M
What is the latest annual profit for Visioneering Technologies?
The latest annual profit of Visioneering Technologies is USD -3.45M
What is the registered address of Visioneering Technologies?
The registered address for Visioneering Technologies is 4555 MANSELL ROAD, SUITE 300, ATLANTA, GEORGIA, 30022
What is the Visioneering Technologies website address?
The website address for Visioneering Technologies is www.vtivision.com
Which industry sector does Visioneering Technologies operate in?
Visioneering Technologies operates in the MED, DENTAL, HOSP EQ-WHSL sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TNCTrue North Copper Limited
AUD 0.45
(1,400.00%)
375.36k
KATOKatana Capital
AUD 0.006
(100.00%)
425k
EUROBEuropean Lithium Limited
AUD 0.002
(100.00%)
1.95M
TM1OTerra Metals Ltd
AUD 0.03
(66.67%)
38.27k
WC1OWest Cobar Metals Ltd
AUD 0.007
(40.00%)
143k
WYXOWestern Yilgarn NL
AUD 0.002
(-75.00%)
1M
PEBPacific Edge Limited
AUD 0.054
(-61.43%)
634.61k
OSLOCOncoSil Medical Ltd
AUD 0.001
(-50.00%)
5.04M
RDNRaiden Resources Limited
AUD 0.008
(-42.86%)
127.5M
GMNGold Mountain Limited
AUD 0.002
(-33.33%)
32.03M
RDNRaiden Resources Limited
AUD 0.008
(-42.86%)
127.5M
SGRStar Entertainment Group Limited
AUD 0.125
(11.11%)
99.31M
DUBDubber Corporation Limited
AUD 0.041
(0.00%)
55.15M
SYASayona Mining Limited
AUD 0.024
(-4.00%)
44.07M
TMGTrigg Minerals Ltd
AUD 0.049
(-7.55%)
33.43M

Discussion

View Full Feed
martyDg martyDg 2 minutes ago
In a few weeks? What facts are you even talking about? Nobody here, not even the management, has any idea when the decision is coming. It’s already been a year! Are you seriously going to keep saying we’re weeks closer if, after two years, there’s still no decision? Don’t even start with the nonsens
NWBO
linkvest linkvest 2 minutes ago
https://eranb1.sg-host.com/
ASII
Trooperstocks Trooperstocks 2 minutes ago
Our Technology
SGTM uses disruptive technologies to transform biological waste into highly nutrient-rich products that impact both health and the environment!
SGTM
OnlyCredibleFactsMatter OnlyCredibleFactsMatter 2 minutes ago
You must not have been in the right stocks that went up significantly in 21 then. And have not looked at the charts that did. Saying that OTC did nothing in 21 is not true.
SRMX
glenn1919 glenn1919 2 minutes ago
zbia....................................https://stockcharts.com/h-sc/ui?s=zbia&p=W&b=5&g=0&id=p86431144783
ZBAI
FeMike FeMike 3 minutes ago
Yes indeed and with a revenue of $4 billion in the near future (within 1 to 2 years) an MC of almost $100 billion.

That you can't understand the absolute impossibility of this scenario shows me the type of person I am dealing with.

A market cap of $35 billion on approva
NWBO
Steady_T Steady_T 3 minutes ago
That same thought occurred to me as I read that P3 P4 sentence.
Perhaps he was referring to AD as P4 and other indications P3 trials... Using the dosing lessons learned. Transferring that learning to other trials makes sense.

I did notice that night time dosing was not mention
AVXL
haha11 haha11 4 minutes ago
$SPX.. ..15...2Ds......DLY trend LL...Needed trend HH...1/13/205

https://schrts.co/fUWXmwaj
SPX
JusDePomme JusDePomme 4 minutes ago
AFFU volume in let's go
AFFU
getmoreshares getmoreshares 4 minutes ago
Blue Hat Interactive Entertainment Technology (“Blue Hat” or the “Company”) (NASDAQ: BHAT), today announced that it has entered into securities purchase agreements with several institutional investors to purchase an aggregate of 77,989,800 Ordinary Shares (the “Ordinary Shares”) in a registered dire
BHAT
JB51 JB51 4 minutes ago
Just need patience with them, report wasn't that bad, broke even, doing good things, just need federal government to approve pot and will rocket higher 
TLRY
ALERTS100%to10000%GAIN ALERTS100%to10000%GAIN 4 minutes ago
AEXAY~~.0025, was $1.16,About Atos

Atos is a global leader in digital transformation with c. 82,000 employees and annual revenue of c. € 10 billion. European number one in cybersecurity, cloud and high-performance computing, the Group provides tailored end-to-end solutions for all ind
AEXAY
georgie18 georgie18 4 minutes ago
SGLY...$2.34...HOD...🥳...Beauty bounce...

georgie18

Member Level
Re: georgie18 post# 122

Saturday, January 11, 2025 3:52:43 PM

Post#
125
of 125
SGLY...$2.18...🥳... Bullish Harami Reversal Patte
SGLY
DewDiligence DewDiligence 4 minutes ago
Kailera/Hengrui phase-2 obesity data:

https://www.globenewswire.com/news-release/2025/01/13/3008465/0/en/Jiangsu-Hengrui-Pharmaceuticals-and-Kailera-Therapeutics-Report-Positive-Topline-Data-from-8-mg-Dose-of-Phase-2-Obesity-Trial-of-GLP-1-GIP-Receptor-Dual-Agonist-HRS9531.html
GLP
georgie18 georgie18 4 minutes ago
SGLY...$2.34...HOD...🥳...Beauty bounce...

georgie18

Member Level
Re: georgie18 post# 122

Saturday, January 11, 2025 3:52:43 PM

Post#
125
of 125
SGLY...$2.18...🥳... Bullish Harami Reversal Patte
SGLY
dexprs dexprs 4 minutes ago
Abercrombie & Fitch Increases Q4 Net Sales Growth Outlook To 7% - 8% From Prior Range Of 5% - 7%; FY24 Net Sales Of Around 15% Vs. Prior Range Of 14% - 15%
BENZINGA 7:15 AM ET 1/13/2025
"In 2025, we will look to continue sustainable, profitable growth through the execution of our play
Tiger Money Tiger Money 4 minutes ago
Got it 
KULR
georgie18 georgie18 4 minutes ago
SGLY...$2.34...HOD...🥳...Beauty bounce...

georgie18

Member Level
Re: georgie18 post# 122

Saturday, January 11, 2025 3:52:43 PM

Post#
125
of 125
SGLY...$2.18...🥳... Bullish Harami Reversal Patte
SGLY
thttlpckg thttlpckg 5 minutes ago
If appeal fails, won't they owe right away? Doubt plaintiff will wait for IPIX to succeed/fail.
IPIX
StockItOut StockItOut 5 minutes ago
True, yet how do you know that they are not BMXI's workers? Nils shaking hands with one mine worker.

I would have thought you'd have caught, that: all the trucks hauling ore within and from a huge pit mine, as the looping video of Brookmount Gold's website's central home page... that
BMXI
gdog gdog 5 minutes ago
huge mistake on my part on this one, don't usually make this kind of blunder at any rate now becoming a long hold.. southern California eletic company...
trading.jeff trading.jeff 5 minutes ago
$OXY uptrend is like a moonshot from the time Berkshire Hathaway averaged down in December. 🌙🚀
OXY
Dawgpound1 Dawgpound1 6 minutes ago
. 25 and dollar estimates and we can't even hold 3 cents you guys are delusional lmfao
CEOS
KILLAZILLA KILLAZILLA 6 minutes ago
you UNDERSTAND NOTHING ABOUT PATENT LAW!!!!

MAKES you AN IMBECILE!!!

EVEN IF xeri WASN'T A COMPLETE SCAM, WHICH WE ALL KNOW IT IS. they STILL CAN'T INFRINGE...

xeri IS TIED UP IN LAWSUITS. they DEFAULTED ON LOANS AND HAVE MASSIVE DEBT BECAUSE OF IT. they
XERI

Your Recent History

ASX
VTI
Visioneering Technologies
BIT
C2U
CASAM ETF Short Msci USA...
BIT
UI481X
UniCredit
BIT
F13404
Vontobel Financial Produ...
BIT
F13737
Vontobel Financial Produ...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads